Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VNDAVanda Pharmaceuticals Inc.

Nasdaq · CIK 0001347178
Filer categoryAccelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts424

Identity from submissions API

NameVanda Pharmaceuticals Inc.
CIK0001347178
TickersVNDA
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC2834 Pharmaceutical Preparations
EIN030491827
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone202-734-3400
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2200 PENNSYLVANIA AVE NW
SUITE 300E
WASHINGTON
DC
20037
DC
Mailing address
2200 PENNSYLVANIA AVE NW
SUITE 300E
WASHINGTON
DC
20037
DC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1339 filing rows loaded from submissions recent; extra archives: CIK0001347178-submissions-001.json (337 filings, 2005-12-29 to 2009-07-11).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K 8-K 1.01 0001628280-26-075166 001-34186 261576670 34 152198 1 1
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000261 005-82196 261549356 34 8982
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000739 005-82196 261538388 34 8073
2026-11-05 4 4 0001193125-26-449902 8820
2026-10-29 10-Q 10-Q 0001347178-26-000002 001-34186 261497587 34 7150578 1 1
2026-10-28 8-K 8-K 2.02,9.01 0001628280-26-067886 001-34186 261495793 34 371875 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-001132 005-82196 261490543 34 10949
2026-10-09 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-115112 005-82196 261453795 34 19968
2026-08-19 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-098866 005-82196 261296757 34 15273
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000170 005-82196 261270621 34 8790
2026-08-06 10-Q 10-Q 0001628280-26-053855 001-34186 261246041 34 7168445 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001628280-26-053308 001-34186 261243321 34 382093 1 1
2026-06-08 4 4 0001193125-26-261871 5040
2026-06-08 4 4 0001193125-26-261811 4864
2026-06-08 4 4 0001193125-26-261806 4821
2026-06-08 4 4 0001193125-26-261800 4792
2026-06-08 4 4 0001193125-26-261790 4904
2026-06-08 4 4 0001193125-26-261782 4881
2026-06-08 4 4 0001193125-26-261768 4906
2026-06-08 3 3 0001193125-26-261752 6954
2026-06-05 S-8 S-8 0001628280-26-041303 333-296555 261069899 33 608396 1 1
2026-06-05 8-K 8-K 5.07 0001628280-26-041298 001-34186 261069795 34 166577 1 1
2026-05-20 4 4 0001802653-26-000003 4683
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000309 005-82196 26967130 34 8105
2026-05-07 10-Q 10-Q 0001628280-26-031667 001-34186 26950772 34 6382992 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001628280-26-031241 001-34186 26948298 34 339608 1 1
2026-05-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001496 333-293404 26945577 33 1775
2026-04-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000465 005-82196 26916030 34 11000
2026-04-24 CORRESP filename1.htm 0001193125-26-177526 14472
2026-04-24 4 4 0002130896-26-000008 4880
2026-04-24 3 3 0002130896-26-000006 3035
2026-04-23 ARS ARS 0001628280-26-026899 001-34186 26889404 34 24422064
2026-04-23 DEFA14A DEFA14A 0001628280-26-026896 001-34186 26889379 34 375161
2026-04-23 DEF 14A DEF 14A 0001628280-26-026893 001-34186 26889364 34 3891161 1 1
2026-04-22 8-K 8-K 5.02,9.01 0001628280-26-026642 001-34186 26884802 34 239983 1 1
2026-04-13 3 3 0002128392-26-000003 9359
2026-04-13 3 3 0002128384-26-000003 13250
2026-04-02 8-K 8-K 5.02 0001628280-26-023222 001-34186 26834251 34 144293 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002588 005-82196 26805167 34 7215
2026-03-10 8-K 8-K 7.01 0001628280-26-016516 001-34186 26740054 34 146258 1 1
2026-03-04 4 4 0001748392-26-000002 5373
2026-03-04 4 4 0001806596-26-000002 6061
2026-03-04 4 4 0001785888-26-000002 5345
2026-03-04 4 4 0001355537-26-000002 5407
2026-03-04 4 4 0001702031-26-000002 5342
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-086369 001-34186 26710873 33 4306
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-086349 001-34186 26710822 33 4343
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-086325 001-34186 26710796 33 4347
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-086321 001-34186 26710788 33 4407
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-086301 001-34186 26710757 33 4362
2026-02-24 4 4 0001193125-26-067185 4366
2026-02-23 144 xsl144X01/primary_doc.xml 0001193125-26-064742 001-34186 26667107 33 5363
2026-02-23 8-K 8-K 8.01,9.01 0001628280-26-010376 001-34186 26662040 34 273755 1 1
2026-02-19 4 4 0001193125-26-059792 4986
2026-02-19 4 4 0001193125-26-059784 4983
2026-02-19 4 4 0001193125-26-059781 5014
2026-02-19 4 4 0001193125-26-059778 5701
2026-02-19 4 4 0001193125-26-059770 5047
2026-02-19 8-K 8-K 5.02,9.01 0001628280-26-009805 001-34186 26654944 34 222726 1 1
2026-02-18 UPLOAD filename1.pdf 0000000000-26-001642 333-293404 40151
2026-02-12 S-3 S-3 0001628280-26-007476 333-293404 26623402 33 1184859 1 1
2026-02-12 10-K 10-K 0001628280-26-007460 001-34186 26623364 34 12380344 1 1
2026-02-11 8-K 8-K 2.02,9.01 0001628280-26-007256 001-34186 26620686 34 391598 1 1
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-26-000212 005-82196 26545748 34 10911
2026-01-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-002483 005-82196 26523316 34 15595
2026-01-08 8-K 8-K 8.01,9.01 0001628280-26-001273 001-34186 26517344 34 238973 1 1
2025-12-31 8-K 8-K 8.01,9.01 0001628280-25-059155 001-34186 251615435 34 251945 1 1
2025-12-04 8-K 8-K 8.01,9.01 0001628280-25-055393 001-34186 251550269 34 232242 1 1
2025-11-28 8-K 8-K 8.01,9.01 0001628280-25-054225 001-34186 251532391 34 233043 1 1
2025-10-30 10-Q 10-Q 0001628280-25-047317 001-34186 251432204 34 6437958 1 1
2025-10-29 8-K 8-K 2.02,9.01 0001628280-25-047112 001-34186 251430015 34 363345 1 1
2025-10-01 8-K 8-K 8.01,9.01 0001628280-25-043489 001-34186 251365484 34 237107 1 1
2025-08-08 4 4 0000950170-25-105819 4457
2025-07-31 10-Q 10-Q 0001628280-25-036861 001-34186 251169655 34 6385589 1 1
2025-07-31 8-K 8-K 2.02,9.01 0001628280-25-036843 001-34186 251169443 34 353702 1 1
2025-07-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-064754 005-82196 251096852 34 15208
2025-06-16 4 4 0000950170-25-087025 4961
2025-06-13 144 xsl144X01/primary_doc.xml 0000950170-25-086506 001-34186 251048420 33 5351
2025-06-09 4 4 0000950170-25-083890 4769
2025-06-09 4 4 0000950170-25-083889 4727
2025-06-09 4 4 0000950170-25-083888 4655
2025-06-09 4 4 0000950170-25-083885 4744
2025-06-09 4 4 0000950170-25-083884 4768
2025-06-05 S-8 S-8 0001628280-25-029697 333-287808 251027764 33 600000 1 1
2025-06-05 8-K 8-K 5.07 0001628280-25-029678 001-34186 251027591 34 166461 1 1
2025-05-27 DEFA14A DEFA14A 0001628280-25-027698 001-34186 25984165 34 32398
2025-05-21 4 4 0000950170-25-076012 5821
2025-05-19 4 4 0000950170-25-074565 5037
2025-05-08 10-Q 10-Q 0001628280-25-023448 001-34186 25923819 34 6099212 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001628280-25-023154 001-34186 25921355 34 499957 1 1
2025-04-25 ARS ARS 0001628280-25-019996 001-34186 25874709 34 21806270
2025-04-25 DEFA14A DEFA14A 0001628280-25-019992 001-34186 25874665 34 303273
2025-04-25 DEF 14A DEF 14A 0001628280-25-019987 001-34186 25874625 34 3582738 1 1
2025-04-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000361 005-82196 25840350 34 10754
2025-03-17 8-K 8-K 7.01 0001193125-25-055287 001-34186 25742586 34 193741 1 1
2025-03-06 4 4 0000950170-25-034966 5830
2025-03-05 4 4 0000950170-25-033845 5830
2025-03-04 4 4 0000950170-25-032285 4742
2025-03-04 4 4 0000950170-25-032281 4739
2025-03-04 4 4 0000950170-25-032276 6718
2025-03-04 4 4 0000950170-25-032273 5459
2025-03-04 4 4 0000950170-25-032270 4770
2025-02-28 4 4 0000950170-25-030176 4463
2025-02-27 4 4 0000950170-25-029059 4463
2025-02-26 4 4 0000950170-25-027860 5830
2025-02-25 4 4 0000950170-25-027056 5044
2025-02-24 4 4 0000950170-25-025914 5118
2025-02-20 4 4 0000950170-25-024498 4991
2025-02-20 4 4 0000950170-25-024489 5049
2025-02-20 4 4 0000950170-25-024487 5706
2025-02-20 4 4 0000950170-25-024486 4988
2025-02-20 4 4 0000950170-25-024485 5019
2025-02-20 8-K 8-K 5.02 0001193125-25-030780 001-34186 25646134 34 203420 1 1
2025-02-14 10-K 10-K 0001628280-25-005761 001-34186 25629755 34 11705956 1 1
2025-02-13 8-K 8-K 2.02,9.01 0001628280-25-005406 001-34186 25620265 34 434010 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000166 005-82196 25600797 34 11088
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001341 005-82196 25592310 34 11955
2025-01-27 8-K 8-K 7.01 0001193125-25-012740 001-34186 25555821 34 185397 1 1
2024-11-18 4 4 0000950170-24-128115 4970
2024-11-14 144 xsl144X01/primary_doc.xml 0000950170-24-127062 001-34186 241462218 33 4344
2024-11-07 10-Q 10-Q 0001628280-24-045970 001-34186 241433118 34 6123323 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001628280-24-045724 001-34186 241431219 34 431902 1 1
2024-10-15 8-K 8-K 8.01,9.01 0001193125-24-237220 001-34186 241369324 34 203739 1 1
2024-10-03 8-K 8-K 5.03,9.01 0001193125-24-232306 001-34186 241352284 34 397277 1 1
2024-09-19 8-K 8-K 8.01,9.01 0001193125-24-221784 001-34186 241309134 34 210395 1 1
2024-08-08 8-A12B/A 8-A12B/A 0001193125-24-196495 001-34186 241186109 34 19746
2024-08-08 8-K 8-K 1.01,3.03,9.01 0001193125-24-196481 001-34186 241186054 34 222578 1 1
2024-08-01 10-Q 10-Q 0001628280-24-033866 001-34186 241164160 34 6003077 1 1
2024-07-31 8-K 8-K 2.02,9.01 0001628280-24-033743 001-34186 241161900 34 426814 1 1
2024-07-29 4 4 0000950170-24-087381 5546
2024-07-29 144 xsl144X01/primary_doc.xml 0000950170-24-087370 001-34186 241153487 33 4341
2024-06-20 8-K 8-K 8.01,9.01 0001193125-24-164545 001-34186 241057247 34 204709 1 1
2024-06-13 8-K 8-K 8.01,9.01 0001193125-24-160755 001-34186 241041785 34 209382 1 1
2024-06-06 8-K 8-K 7.01,9.01 0001193125-24-156117 001-34186 241025909 34 222424 1 1
2024-05-24 8-K 8-K 8.01,9.01 0001628280-24-025254 001-34186 24985212 34 283742 1 1
2024-05-24 4 4 0000950170-24-064669 7035
2024-05-24 8-K/A 8-K/A 5.07 0001628280-24-025241 001-34186 24984958 34 216277 1 1
2024-05-21 4 4 0000950170-24-063022 7052
2024-05-21 4 4 0000950170-24-063019 6964
2024-05-21 4 4 0000950170-24-063017 7077
2024-05-21 4 4 0000950170-24-063015 7076
2024-05-21 S-8 S-8 0001628280-24-024550 333-279591 24969968 33 484192
2024-05-20 8-K 8-K 5.07 0001628280-24-024405 001-34186 24965972 34 222605 1 1
2024-05-13 DEFA14A DEFA14A 0001193125-24-137238 001-34186 24939276 34 24925
2024-05-09 DEFA14A DEFA14A 0001193125-24-135393 001-34186 24931917 34 822069
2024-05-09 10-Q 10-Q 0001628280-24-021952 001-34186 24928514 34 5735941 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001628280-24-021658 001-34186 24925872 34 415737 1 1
2024-05-07 8-K 8-K 8.01,9.01 0001193125-24-133252 001-34186 24922870 34 192410 1 1
2024-05-03 8-A12B/A 8-A12B/A 0001193125-24-130778 001-34186 24913539 34 19404
2024-05-03 8-K 8-K 1.01,3.03,9.01 0001193125-24-130668 001-34186 24912882 34 209362 1 1
2024-04-29 ARS/A AMENDMENT TO ANNUAL REPORT 0001213900-24-037204 001-34186 24891439 34 766263
2024-04-29 ARS ANNUAL REPORT 0001213900-24-036807 001-34186 24886442 34 764893
2024-04-29 DEF 14A PROXY STATEMENT 0001213900-24-036802 001-34186 24886419 34 12427774 1 1
2024-04-17 8-A12B 8-A12B 0001193125-24-099263 001-34186 24852085 34 34956
2024-04-17 8-K 8-K 1.01,3.03,5.03,8.01,9.01 0001193125-24-099251 001-34186 24851999 34 691799 1 1
2024-04-03 8-K 8-K 8.01,9.01 0001193125-24-086031 001-34186 24819296 34 195639 1 1
2024-03-07 8-K 8-K 8.01,9.01 0001193125-24-062241 001-34186 24730620 34 158486 1 1
2024-03-06 4 4 0000950170-24-027266 7340
2024-03-06 4 4 0000950170-24-027259 7312
2024-03-06 4 4 0000950170-24-027256 7372
2024-03-06 4 4 0000950170-24-027253 8026
2024-03-06 4 4 0000950170-24-027249 7309
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025255 001-34186 24717969 33 4341
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025251 001-34186 24717966 33 4310
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025247 001-34186 24717959 33 4449
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025245 001-34186 24717956 33 4346
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025243 001-34186 24717954 33 4309
2024-02-21 4 4 0000950170-24-018033 5019
2024-02-21 4 4 0000950170-24-018032 4993
2024-02-21 4 4 0000950170-24-018027 5706
2024-02-21 4 4 0000950170-24-018030 5052
2024-02-21 4 4 0000950170-24-018024 4991
2024-02-21 8-K 8-K 5.02 0001193125-24-041514 001-34186 24660172 34 157375 1 1
2024-02-16 8-K/A 8-K/A 9.01 0001193125-24-038517 001-34186 24648890 34 381100 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022210 005-82196 24629790 34 13097
2024-02-13 SC 13G/A vnda-13g_20231231.txt 0001037389-24-000067 005-82196 24623431 34 13466
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000354204-24-003342 005-82196 24612572 34 19505
2024-02-08 10-K 10-K 0001628280-24-003785 001-34186 24606853 34 10739145 1 1
2024-02-07 8-K 8-K 2.02,9.01 0001628280-24-003693 001-34186 24604329 34 385216 1 1
2024-02-05 8-K 8-K 8.01,9.01 0001193125-24-024112 001-34186 24596224 34 161858 1 1
2024-01-23 SC 13G/A us9216591084_012324.txt 0001086364-24-001408 005-82196 24551331 34 13532
2024-01-22 SC 13G/A Vanda_Phar_Inc.txt 0000093751-24-000046 005-82196 24547526 34 8477
2023-12-15 8-K 8-K 5.03,9.01 0001193125-23-296659 001-34186 231490523 34 352454 1 1
2023-12-07 8-K 8-K 1.01,2.01,8.01,9.01 0001193125-23-290779 001-34186 231473323 34 194176 1 1
2023-11-09 10-Q 10-Q 0001628280-23-038029 001-34186 231390003 34 5768092 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001628280-23-037827 001-34186 231387790 34 358765 1 1
2023-10-06 SC 13G/A us9216591084_100523.txt 0001306550-23-010078 005-82196 231313908 34 13563
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047056 5074
2023-08-21 8-K 8-K 8.01 0001193125-23-217063 001-34186 231189983 34 142934 1 1
2023-08-21 144 xsl144X01/primary_doc.xml 0001802653-23-000002 001-34186 231189915 33 4239
2023-08-11 4 FORM 4 SUBMISSION 0001209191-23-045447 5117
2023-08-10 144 xsl144X01/primary_doc.xml 0001983609-23-000002 001-34186 231160885 33 4278
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-043990 7354
2023-07-28 144 xsl144X01/primary_doc.xml 0001983609-23-000001 001-34186 231123542 33 4930
2023-07-28 10-Q 10-Q 0001628280-23-026000 001-34186 231120176 34 5334003 1 1
2023-07-27 8-K 8-K 2.02,9.01 0001628280-23-025916 001-34186 231118421 34 360281 1 1
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038417 5835
2023-06-15 144 xsl144X01/primary_doc.xml 0001730052-23-000002 001-34186 231018775 33 8225
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037326 5149
2023-06-13 144 xsl144X01/primary_doc.xml 0001730052-23-000001 001-34186 231012733 33 4272
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036289 7386
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036285 7387
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036282 7362
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036280 7273
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036275 7345
2023-06-08 S-8 S-8 0001628280-23-021546 333-272522 231002599 33 470870
2023-06-08 8-K 8-K 5.07 0001628280-23-021539 001-34186 231002516 34 203274 1 1
2023-05-11 8-K 8-K 8.01,9.01 0001193125-23-141366 001-34186 23908743 34 178356 1 1
2023-05-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-05 16:30:00 9999999995-23-001312 333-269654 23895716 33 1733
2023-05-03 CORRESP filename1.htm 0001193125-23-134561 10026
2023-05-03 S-3/A S-3/A 0001193125-23-134544 333-269654 23885293 33 76304
2023-05-03 10-Q 10-Q 0001628280-23-015267 001-34186 23885083 34 5492311 1 1
2023-05-03 8-K 8-K 2.02,9.01 0001628280-23-015206 001-34186 23883658 34 355871 1 1
2023-04-24 ARS ARS 0001628280-23-012597 001-34186 23840962 34 18634343
2023-04-24 DEFA14A DEFA14A 0001628280-23-012596 001-34186 23840949 34 819620
2023-04-24 DEF 14A DEF 14A 0001628280-23-012594 001-34186 23840936 34 5400310 1 1
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019714 7625
2023-03-17 3 FORM 3 SUBMISSION 0001209191-23-019711 2969
2023-03-17 8-K 8-K 5.02,9.01 0001628280-23-008386 001-34186 23740656 34 252613 1 1
2023-03-13 8-K 8-K 7.01 0001628280-23-007646 001-34186 23725964 34 174585 1 1
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016464 7708
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016463 7142
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016462 7740
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016461 8398
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016460 7678
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011343 7693
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011342 7665
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011341 7729
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011340 8380
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011338 7663
2023-02-17 8-K 8-K 5.02 0001193125-23-042033 001-34186 23643129 34 159691 1 1
2023-02-16 UPLOAD filename1.pdf 0000000000-23-001606 40344
2023-02-14 SC 13G/A vanda.txt 0001306923-23-000008 005-82196 23629875 34 275522
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038526 005-82196 23626513 34 97805
2023-02-13 SC 13G/A vnda-13g_20221231.txt 0001037389-23-000060 005-82196 23615860 34 13390
2023-02-10 SC 13G SEC SCHEDULE 13G 0000354204-23-001724 005-82196 23611072 34 19414
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-017219 005-82196 23604482 34 13015
2023-02-09 S-3 S-3 0001193125-23-029269 333-269654 23601230 33 1565880
2023-02-09 10-K 10-K 0001628280-23-002857 001-34186 23601076 34 10123117 1 1
2023-02-08 8-K 8-K 2.02,9.01 0001628280-23-002764 001-34186 23599182 34 377664 1 1
2023-02-07 SC 13G/A Vanda_Pharmaceuticals_Inc.txt 0000093751-23-000329 005-82196 23594462 34 8504
2023-01-24 SC 13G/A us9216591084_012423.txt 0001306550-23-002977 005-82196 23547388 34 13251
2022-12-23 8-K 8-K 8.01 0001193125-22-311271 001-34186 221483159 34 143635 1 1
2022-12-16 8-K 8-K 8.01,9.01 0001193125-22-307491 001-34186 221468867 34 158804 1 1
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061673 5112
2022-12-14 8-K 8-K 8.01,9.01 0001193125-22-304290 001-34186 221461095 34 164447 1 1
2022-12-07 4 FORM 4 SUBMISSION 0001209191-22-060227 15156
2022-12-07 4 FORM 4 SUBMISSION 0001209191-22-060225 10004
2022-11-03 10-Q 10-Q 0001628280-22-027951 001-34186 221356135 34 5863160 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001628280-22-027812 001-34186 221354083 34 387332 1 1
2022-08-29 4 FORM 4 SUBMISSION 0001209191-22-047887 6885
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047210 5044
2022-08-17 4 FORM 4 SUBMISSION 0001209191-22-046228 7134
2022-08-04 10-Q 10-Q 0001628280-22-020848 001-34186 221134583 34 5695465 1 1
2022-08-03 8-K 8-K 2.02,9.01 0001628280-22-020607 001-34186 221132705 34 383601 1 1
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043682 5758
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038449 7356
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038448 7357
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038447 7243
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038446 7315
2022-06-17 S-8 S-8 0001347178-22-000006 333-265692 221024043 33 460744
2022-06-16 8-K 8-K 5.07 0001347178-22-000003 001-34186 221020785 34 196383 1 1
2022-06-14 4 FORM 4 SUBMISSION 0001209191-22-036835 5369
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034062 9075
2022-06-02 4 FORM 4 SUBMISSION 0001209191-22-033561 9075
2022-05-06 10-Q 10-Q 0001628280-22-012834 001-34186 22898806 34 5464558 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001628280-22-012673 001-34186 22896655 34 542871 1 1
2022-04-25 DEFA14A DEFA14A 0001628280-22-010129 001-34186 22850129 34 1186949
2022-04-25 DEF 14A DEF 14A 0001628280-22-010125 001-34186 22850093 34 2645053
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-015160 10254
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-015158 10224
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-015157 11855
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-015155 12503
2022-03-02 4 FORM 4 SUBMISSION 0001209191-22-015154 11787
2022-03-01 8-K 8-K 5.02 0001193125-22-061308 001-34186 22697957 34 166189 1 1
2022-02-24 10-K 10-K 0001628280-22-003629 001-34186 22666470 34 10815622 1 1
2022-02-23 8-K 8-K 2.02,9.01 0001628280-22-003504 001-34186 22663641 34 405703 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042673 005-82196 22636873 34 70457
2022-02-14 SC 13G/A vanda.txt 0001306923-22-000011 005-82196 22634531 34 11743
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-040407 005-82196 22627233 34 114822
2022-02-14 SC 13G/A VANDA_PHARMACEUTICALS_INC.txt 0000093751-22-000360 005-82196 22624198 34 8480
2022-02-11 SC 13G/A vnda-13g_20211231.txt 0001037389-22-000203 005-82196 22620466 34 13388
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018821 005-82196 22611095 34 13010
2022-02-04 8-K 8-K 8.01,9.01 0001193125-22-027687 001-34186 22590959 34 173335 1 1
2022-01-27 SC 13G/A us9216591084_012722.txt 0000834237-22-002684 005-82196 22564285 34 13275
2022-01-26 SC 13G/A us9216591084_012622.txt 0000834237-22-001286 005-82196 22556120 34 13275
2022-01-14 8-K 8-K 1.01,9.01 0001193125-22-009851 001-34186 22531930 34 170155 1 1
2021-12-02 4 FORM 4 SUBMISSION 0001209191-21-067592 15156
2021-11-04 10-Q 10-Q 0001347178-21-000032 001-34186 211377974 34 5780427 1 1
2021-11-03 8-K 8-K 2.02,9.01 0001347178-21-000030 001-34186 211375392 34 413625 1 1
2021-10-08 8-K 8-K 5.02 0001193125-21-295465 001-34186 211315389 34 144115 1 1
2021-09-17 4 FORM 4 SUBMISSION 0001209191-21-056530 13501
2021-09-13 4 FORM 4 SUBMISSION 0001209191-21-055685 13164
2021-08-23 4 FORM 4 SUBMISSION 0001209191-21-052965 5613
2021-08-17 4 FORM 4 SUBMISSION 0001209191-21-051865 5641
2021-07-30 4 FORM 4 SUBMISSION 0001209191-21-048738 6328
2021-07-29 10-Q 10-Q 0001347178-21-000028 001-34186 211124770 34 5680990 1 1
2021-07-28 8-K 8-K 2.02,9.01 0001347178-21-000025 001-34186 211122613 34 378258 1 1
2021-07-27 4 FORM 4 SUBMISSION 0001209191-21-048276 5617
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041496 9487
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040615 5539
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040244 7244
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040243 7356
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040240 7357
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040237 7243
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040236 7315
2021-06-10 S-8 S-8 0001347178-21-000022 333-256994 211008872 33 446894
2021-06-10 8-K 8-K 5.07,8.01 0001347178-21-000021 001-34186 211008820 34 200450 1 1
2021-05-06 10-Q 10-Q 0001347178-21-000015 001-34186 21895709 34 5353841 1 1
2021-05-05 8-K 8-K 2.02,9.01 0001347178-21-000013 001-34186 21893220 34 364931 1 1
2021-04-22 DEFA14A DEFA14A 0001347178-21-000009 001-34186 21843237 34 1003473
2021-04-22 DEF 14A DEF 14A 0001347178-21-000008 001-34186 21843232 34 2238907
2021-03-16 4 FORM 4 SUBMISSION 0001209191-21-020782 9466
2021-03-09 4 FORM 4 SUBMISSION 0001209191-21-019118 5091
2021-03-08 4 FORM 4 SUBMISSION 0001209191-21-018651 6124
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017280 7705
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017278 5612
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017276 7687
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017274 8430
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017273 5617
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017272 7681
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014886 7695
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014882 7666
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014878 7642
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014876 8382
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014873 14054
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-014869 7633
2021-02-25 8-K 8-K 5.02 0001193125-21-055675 001-34186 21676355 34 161116 1 1
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012205 9079
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-012204 9078
2021-02-16 SC 13G/A d8800923_13g-a.htm 0000919574-21-001697 005-82196 21640692 34 94422
2021-02-16 SC 13G/A Vanda_13G_A9.txt 0001306923-21-000020 005-82196 21640029 34 276206
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-040098 005-82196 21622981 34 127301
2021-02-11 SC 13G/A vnda-13g_20201231.txt 0001037389-21-000317 005-82196 21618795 34 13389
2021-02-11 SC 13G VandaPharmaceuticalsInc.txt 0000093751-21-000257 005-82196 21616901 34 8421
2021-02-11 10-K 10-K 0001347178-21-000005 001-34186 21616644 34 10864966 1 1
2021-02-10 8-K 8-K 2.02,9.01 0001347178-21-000002 001-34186 21613841 34 395643 1 1
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019336 005-82196 21612237 34 13878
2021-01-25 SC 13G us9216591084_012521.txt 0000834237-21-000440 005-82196 21550204 34 13271
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063474 20963
2020-12-02 8-K 8-K 8.01,9.01 0001193125-20-307818 001-34186 201362387 34 170719 1 1
2020-10-29 10-Q 10-Q 0001347178-20-000030 001-34186 201270436 34 5839526 1 1
2020-10-28 8-K 8-K 2.02,9.01 0001347178-20-000027 001-34186 201268673 34 392458 1 1
2020-08-21 4 FORM 4 SUBMISSION 0001209191-20-047991 5614
2020-08-18 8-K 8-K 8.01,9.01 0001193125-20-223727 001-34186 201114600 34 472000 1 1
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046965 5641
2020-08-14 4 FORM 4 SUBMISSION 0001209191-20-046804 5122
2020-08-06 10-Q 10-Q 0001347178-20-000024 001-34186 201079736 34 6502911 1 1
2020-08-05 8-K 8-K 2.02,9.01 0001347178-20-000022 001-34186 201077259 34 452338 1 1
2020-07-29 4 FORM 4 SUBMISSION 0001209191-20-043999 8369
2020-07-29 4 FORM 4 SUBMISSION 0001209191-20-043998 5617
2020-07-29 8-K 8-K 5.02,9.01 0001193125-20-202550 001-34186 201057484 34 197958 1 1
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036787 7243
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036785 7354
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036783 7355
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036782 7242
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036780 7314
2020-06-11 S-8 S-8 0001193125-20-166765 333-239103 20957977 33 217239
2020-06-11 8-K 8-K 5.07 0001193125-20-166634 001-34186 20957228 34 166890 1 1
2020-06-02 4 FORM 4 SUBMISSION 0001209191-20-033491 8682
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032896 9221
2020-05-26 DEFA14A DEFA14A 0001347178-20-000019 001-34186 20908109 34 72271
2020-05-26 8-K 8-K 8.01,9.01 0001347178-20-000018 001-34186 20908105 34 240139 1 1
2020-05-13 8-K 8-K 8.01,9.01 0001193125-20-141074 001-34186 20871047 34 166587 1 1
2020-05-07 10-Q 10-Q 0001347178-20-000013 001-34186 20854503 34 5687057 1 1
2020-05-06 8-K 8-K 2.02,9.01 0001193125-20-134914 001-34186 20852825 34 244455 1 1
2020-04-24 CT ORDER filename1.pdf 20200424,20200424 9999999997-20-002129 001-34186 20815620 34 125794
2020-04-22 DEFA14A DEFA14A 0001347178-20-000010 001-34186 20808031 34 716587
2020-04-22 DEF 14A DEF 14A 0001347178-20-000009 001-34186 20808013 34 2889362
2020-03-24 3 FORM 3 SUBMISSION 0001209191-20-020912 12764
2020-03-13 8-K 8-K 8.01 0001193125-20-073086 001-34186 20713932 34 146300 1 1
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016210 7204
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016208 5598
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016204 7688
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016200 7723
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016197 7683
2020-03-03 8-K 8-K 5.02 0001193125-20-060483 001-34186 20682779 34 177324 1 1
2020-02-28 4 FORM 4 SUBMISSION 0001209191-20-014132 7694
2020-02-28 4 FORM 4 SUBMISSION 0001209191-20-014129 7666
2020-02-28 4 FORM 4 SUBMISSION 0001209191-20-014127 7641
2020-02-28 4 FORM 4 SUBMISSION 0001209191-20-014126 7670
2020-02-28 4 FORM 4 SUBMISSION 0001209191-20-014124 7633
2020-02-26 8-K 8-K 8.01,9.01 0001193125-20-049300 001-34186 20653416 34 911501 1 1
2020-02-26 10-K 10-K 0001347178-20-000003 001-34186 20653273 34 10918203 1 1
2020-02-25 8-K 8-K 2.02,9.01 0001193125-20-048323 001-34186 20650649 34 254850 1 1
2020-02-20 8-K 8-K 5.02 0001193125-20-043567 001-34186 20635601 34 148372 1 1
2020-02-19 4 FORM 4 SUBMISSION 0001209191-20-010516 5601
2020-02-19 3 FORM 3 SUBMISSION 0001209191-20-010513 3575
2020-02-19 8-K 8-K 5.02,9.01 0001193125-20-041266 001-34186 20627378 34 172563 1 1
2020-02-14 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000850 005-82196 20619211 34 55055
2020-02-14 SC 13G/A Vanda_13G_A8.txt 0001306923-20-000012 005-82196 20618597 34 111618
2020-02-14 SC 13G/A d8477782_13g-a.htm 0000919574-20-001427 005-82196 20615736 34 111804
2020-02-13 SC 13G/A SC 13G/A 0001193125-20-035671 005-82196 20611346 34 126730
2020-02-12 SC 13G vnda-13g_20191231.txt 0001037389-20-000046 005-82196 20603138 34 13361
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-20-018247 005-82196 20600505 34 13702
2020-02-04 SC 13G/A us9216591084_020320.txt 0000834237-20-002791 005-82196 20572246 34 13255
2020-02-03 8-K 8-K 8.01,9.01 0001193125-20-022109 001-34186 20566883 34 163294 1 1
2020-01-21 8-K 8-K 5.02 0001193125-20-011029 001-34186 20536485 34 145892 1 1
2020-01-13 8-K 8-K 8.01,9.01 0001193125-20-006403 001-34186 20524365 34 172480 1 1
2020-01-06 4 FORM 4 SUBMISSION 0001209191-20-002032 5590

Latest XBRL company facts

One latest value per concept from companyfacts (424 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 60.47M 2026-10-22 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
dei EntityPublicFloat Entity Public Float USD 268.70M 2025-06-30 2025 FY 10-K 2026-02-12 0001628280-26-007460
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 216.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.42M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 120 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 7.63M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.85M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 67 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001628280-26-026893
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 60.59M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 7.98M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.63M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 60.32M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -117,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-220200
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 127,000 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2011-12-31 2011 FY 10-K 2012-03-09 0001193125-12-105284
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 99,000 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188616
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 43.56M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 43.56M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 11.70M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 12.62M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD -108,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD 42,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -66,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 728.27M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 283,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.34M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 1.63M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap AdvertisingExpense Advertising Expense USD 28.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap AllowanceForFundsUsedDuringConstructionInvestingActivities Allowance for Funds Used During Construction, Investing Activities USD 1.90M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 5.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap Assets Assets USD 382.33M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AssetsCurrent Assets, Current USD 238.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 78.56M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 5,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 100,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 384.47M 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020848
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 100.91M 2016-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 31.62M 2012-12-31 2013 Q3 10-Q 2013-11-08 0001193125-13-433952
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 382.63M 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020848
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 382.63M 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020848
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 61.83M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 1.00M 2013-03-31 2013 Q1 10-Q 2013-05-10 0001193125-13-212435
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 10,000 2012-12-31 2013 Q1 10-Q 2013-05-10 0001193125-13-212435
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 20,000 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 600,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares -2.9 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares -2.9 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -100.74M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 79.33M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 18.99M 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 91,000 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 15.94M 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USD 2.96M 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses Business Combination, Separately Recognized Transactions, Net Gains and Losses USD 59.53M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 61.93M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -6.80M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 62.30M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -23.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 60.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 60.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CommonStockValue Common Stock, Value, Issued USD 60,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -134.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ContractualObligation Contractual Obligation USD 30.27M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 10.67M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 2.42M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 2.81M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 7.80M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 3.34M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 3.23M 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 796,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001347178-18-000010
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD 800,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047317
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 25.70M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 10.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 19.44M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-03 0001193125-16-757991
us-gaap CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization Cost of Goods Sold, Excluding Depreciation, Depletion, and Amortization (Deprecated 2019-01-31) USD 24.49M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap CostsAndExpenses Costs and Expenses USD 309.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 55,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 143,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 185,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent USD 78.66M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 78.56M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 252,000 2014-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 78.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 38,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.85M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 247,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3.10M 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredRevenue Deferred Revenue USD 90.28M 2013-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 314,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 174,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 63.49M 2013-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 30.75M 2014-01-01 2014-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 30.75M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 2.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 420,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 36.67M 2013-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1.50M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 127.25M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 100,000 2016-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 89.07M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2011-12-31 2011 FY 10-K 2012-03-09 0001193125-12-105284
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-09 0001193125-12-105284
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 22.00M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 13.80M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 8.20M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 86,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 18.60M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 20.60M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 3.31M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 6.20M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.43M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 2.10M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 124.40M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 15,000 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 2.85M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 6,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.5 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.06 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap Depreciation Depreciation USD 783,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 420,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-04 0001193125-15-365182
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.04 2017-10-01 2017-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.59 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.775 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.045 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 400,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001347178-20-000013
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.071 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure -0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 40,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 9.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options (Deprecated 2017-01-31) USD 2.21M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-03 0001193125-17-154971
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 2.40M 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-433952
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 2.89M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 2.89M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 343,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 343,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 7.48M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 4.02M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 2.35M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 8.08M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 3.52M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 1.22M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 3.34M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 601,000 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 2.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 5.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 2.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.062 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 36.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 77.35M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 7.95M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 147.89M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 111.13M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD -700,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 23,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 77.62M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 24.59M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap GrossProfit Gross Profit USD 60.87M 2020-10-01 2020-12-31 2020 FY 10-K 2021-02-11 0001347178-21-000005
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -138.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -133.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 23.03M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-07-29 0001347178-21-000028
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 446,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -400,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 140,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 64,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 107.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 126,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -29.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 121,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 968,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 900,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 775,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 796,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD 5.95M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -2.27M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 24.39M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-177216
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 36.19M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-271844
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -30.57M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -330,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 28,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 267,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 8.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 46,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 618,229 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap InventoryNet Inventory, Net USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 8.12M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 198,000 2014-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 33,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 461,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-09 0001193125-12-105284
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3.60M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-11 0001347178-21-000005
us-gaap LeaseCost Lease, Cost USD 5.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.67M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.41M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.10M 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.10M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.16M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 633,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 527,000 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap Liabilities Liabilities USD 182.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 382.33M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap LiabilitiesCurrent Liabilities, Current USD 154.98M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 20.04M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-433952
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 1.00M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 30.75M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -16,000 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -2.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.59M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001347178-19-000014
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 89.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -48.20M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001347178-19-000014
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -109.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 30.16M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001347178-19-000014
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -133.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 200,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 25.00M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-04 0001193125-15-365182
us-gaap NoncashOrPartNoncashAcquisitionInventoryAcquired1 Noncash or Part Noncash Acquisition, Inventory Acquired USD 3.00M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 25.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -137.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.14M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 655,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 14.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 14.22M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 22.76M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.48M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.42M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.35M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.33M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.50M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 10.67M 2018-12-31 2019 FY 10-K 2020-02-26 0001347178-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 599,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001347178-18-000010
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.082 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 228.00M 2016-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.05M 2020-12-31 2020 FY 10-K 2021-02-11 0001347178-21-000005
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.71M 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 28,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap OtherCommitment Other Commitment USD 200,000 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueAfterFifthYear Other Commitment, to be Paid, after Year Five USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueInFifthYear Other Commitment, to be Paid, Year Five USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 200,000 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001347178-19-000003
us-gaap OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear Other Commitment, to be Paid, Remainder of Fiscal Year USD 2.00M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001347178-18-000007
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD -26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax USD -669,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), before Tax (Deprecated 2012-01-31) USD -7.96M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-220200
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD 25,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023448
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 555,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD 6,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-220200
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -695,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 91,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023448
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 6,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001193125-12-220200
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 83,000 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-05 0000950123-11-073247
us-gaap OtherIncome Other Income USD 4.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 28,000 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 10.20M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 4.76M 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 116,000 2011-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD -124,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap PaymentsForRestructuring Payments for Restructuring USD 384,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD -1.82M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 1.60M 2012-04-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 722,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 36.13M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PrepaidInsurance Prepaid Insurance USD 423,000 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap PrepaidRent Prepaid Rent USD 32,000 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188616
us-gaap PrepaidRoyalties Prepaid Royalties USD 1.76M 2016-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-11 0001347178-21-000005
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 77.33M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 99.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 999,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 66,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0001628280-25-005761
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.86M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.03M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap PurchaseObligation Purchase Obligation USD 12.87M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap PurchaseObligationDueAfterFifthYear Purchase Obligation, to be Paid, after Year Five USD 0 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap PurchaseObligationDueInFifthYear Purchase Obligation, to be Paid, Year Five USD 0 2019-09-30 2019 Q3 10-Q 2019-11-07 0001347178-19-000017
us-gaap PurchaseObligationDueInFourthYear Purchase Obligation, to be Paid, Year Four USD 2.60M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 12.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 7.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 2.60M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 93.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 469,000 2025-06-30 2025 Q2 10-Q 2025-07-31 0001628280-25-036861
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 365,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RestructuringCharges Restructuring Charges USD 10,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap RestructuringReserve Restructuring Reserve USD 59,000 2013-12-31 2013 FY 10-K 2014-02-25 0001193125-14-066051
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD -54,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD 264,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001193125-13-212435
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -528.41M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 172.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 489,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-26 0001193125-13-075214
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 2.80M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap Revenues Revenues USD 172.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 6.50M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 11.6 2014-10-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 140.08M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001347178-18-000010
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 25.10M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-433952
us-gaap SecurityDeposit Security Deposit USD 500,000 2011-07-04 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap SecurityDepositLiability Security Deposit Liability USD 500,000 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 199.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 7.74 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 32,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.3 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 492,376 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 7.19 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 1.80M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-461076
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.045 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.011 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-03 0001193125-12-333283
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.5 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 5.07M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.44M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.02 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 545,104 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001347178-20-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 172,735 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.95 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5.87M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.82M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.46 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 5.82M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.59M 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.52 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.82 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 14.29 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001347178-20-000024
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.16 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 7.94 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001193125-16-578637
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 32,386 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 451,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 199.86M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 5.75M 2014-10-01 2014-10-31 2016 FY 10-K 2017-02-17 0001193125-17-047317
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 100.87M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-11 0001347178-21-000005
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap Supplies Prepaid Supplies USD 346,000 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-177216
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 19.57M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 159,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 796,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 87,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 104,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 19.60M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -12.30M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001193125-15-091300
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007460
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 60.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 44.74M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001193125-18-046425
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 60.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001347178-26-000002

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →